Table 2 demographic and clinical characteristics
From: Correlation between human papillomavirus infection and bladder transitional cell carcinoma
Case | Control | |
|---|---|---|
Age | 67 ± 10.8(38–85) | 52 ± 20.3(18–81) |
Sex | ||
Male | 50(84.7%) | 16(80%) |
Female | 9(15.3%) | 4(20%) |
UII | 3(5.1%) | 0 |
Metastasis | ||
Bone | 2 | - |
Lung | 2 | - |
Local lymph nodes | 1 | - |
Both liver & kidney | 2 | - |
Site of lesion in bladder | ||
Dome | 6 | - |
Left lateral | 21 | - |
Right lateral | 14 | - |
Bilateral | 10 | - |
Trigone | 1 | - |
Trigone & right lateral | 2 | - |
Bladder neck | 2 | - |
Diffuse | 2 | - |
Ureteral orifice | 1 | - |
Other simultaneous problems | ||
Hypertension | 7(11.8%) | 2(10%) |
IHD | 5(8.5%) | 0 |
CLL | 0 | 1(5%) |
CRF | 0 | 1(5%) |
DM | 6(10.1%) | 0 |
Asthma | 1(1.7%) | 0 |
Hepatitis | 1(1.7%) | 0 |
Renal Stone | 3(5%) | 0 |
Tuberculosis | 1(1.7%) | 0 |
Hyperthyroidism | 2(3.4%) | 1(5%) |
Neurogenic tumor | 0 | 1(5%) |
Urethral stricture | 0 | 1(5%) |
Number of tumor lesions in cystoscopy | ||
1 | 26(44.1%) | - |
2 | 9(15.3%) | - |
3 | 2(3.4%) | - |
4 | 3(5.1%) | - |
>4 | 19(32.2%) | - |